Studies on inhibition of human platelet response by diltiazem
- 1 January 1990
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 21 (6) , 949-954
- https://doi.org/10.1016/0306-3623(90)90461-t
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Arginine vasopressin release from human platelets after irreversible aggregationClinical Science, 1990
- Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole bloodProstaglandins, Leukotrienes & Essential Fatty Acids, 1989
- Thromboxane formation during blood clotting is decreased by verapamilProstaglandins, Leukotrienes and Medicine, 1984
- The anti-platelet effects of calcium channel blockers add to their anti-anginal propertiesInternational Journal of Cardiology, 1983
- Hypotensive effects of diltiazem to normals and essential hypertensivesEuropean Journal of Clinical Pharmacology, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Inhibition of human platelet function by verapamilThrombosis Research, 1982
- Calcium ions, drug action and platelet functionPharmacology & Therapeutics, 1982
- Studies on the Effect of Adrenergic Blocking Drugs on Catecholamine‐Induced Platelet Aggregation and Uptake of Noradrenaline and 5‐HydroxytryptamineActa Physiologica Scandinavica, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962